Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer

PURPOSE: To prospectively compare HRQoL effects of two modern adjuvant chemotherapy breast cancer treatment regimens at six time-points up to 16 months after random assignment. METHODS: The open-label, randomized, Phase 3 “Panther trial” was conducted between February 2007 and September 2011. 760 wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandberg, Yvonne, Johansson, Hemming, Hellström, Mats, Gnant, Michael, Möbus, Volker, Greil, Richard, Foukakis, Theodoros, Bergh, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182635/
https://www.ncbi.nlm.nih.gov/pubmed/32232698
http://dx.doi.org/10.1007/s10549-020-05602-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182635/
https://www.ncbi.nlm.nih.gov/pubmed/32232698
http://dx.doi.org/10.1007/s10549-020-05602-9

Ejemplares similares